"Polypill" to fight cardiovascular disease: cost effectiveness of statins for primary prevention of cardiovascular events is questionable.
Messori
Andrea
A
Santarlasci
Benedetta
B
Trippoli
Sabrina
S
Vaiani
Monica
M
D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D004338:Drug Combinations; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics*; D011322:Primary Prevention / Q000191:economics
D004338:Drug Combinations; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors